Evidence map›Paper›PMID 41113188›Full record

ReviewFrontiers in psychiatry2025

Neurocognitive mechanisms underlying autism spectrum disorders: a literature review.

Shixian Liu, Dongmei Zeng, Caiying Yi, Meijun Zhu

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Autism care: reimagining the spectrum.Frontiers in child and adolescent psychiatry · 2026
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shixian LiuDepartment of Pediatric Neurological Rehabilitation, Ganzhou Women and Children Health Hospital, Ganzhou, Jiangxi, China.
Dongmei ZengDepartment of Pediatric Neurological Rehabilitation, Ganzhou Women and Children Health Hospital, Ganzhou, Jiangxi, China.
Caiying YiDepartment of Pediatric Neurological Rehabilitation, Ganzhou Women and Children Health Hospital, Ganzhou, Jiangxi, China.
Meijun ZhuDepartment of Pediatric Neurological Rehabilitation, Ganzhou Women and Children Health Hospital, Ganzhou, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Autism spectrum disorder (ASD) is associated with complex neurocognitive alterations that impact social cognition, executive function, and sensory processing. Understanding these mechanisms is essential for advancing diagnosis and treatment strategies. Methods: We conducted an integrative review of recent findings from structural neuroimaging, functional connectivity, molecular biology, cognitive studies, genetics, and epigenetics. Interdisciplinary approaches were summarized to examine regulatory mechanisms involved in neural development and function, as well as their impact on ASD pathophysiology. Results: Evidence from brain imaging studies demonstrates notable structural changes and disrupted neural circuit connectivity, affecting both local and global communication within the brain. Neurotransmitter system dysregulation, particularly involving glutamatergic and GABAergic pathways, contributes to excitation-inhibition imbalance, a hallmark of ASD. Genetic and epigenetic research highlights familial inheritance patterns and gene-environment interactions regulating neurodevelopment. Advancements in neuroimaging biomarkers have improved early diagnosis, while customized treatment approaches targeting specific neurobiological elements are associated with better clinical outcomes. Discussion: This review underscores the importance of a multidimensional framework that integrates imaging, molecular biology, and genetics in understanding ASD. The findings emphasize the heterogeneity of ASD and point to the necessity of individualized treatment strategies. Future research should prioritize early biomarker identification and the development of personalized therapies responsive to neural system complexity and diverse treatment outcomes.

Indexed as

autism spectrum disordergenetic factorsneural circuitsneurocognitive mechanismssynaptic function

Identifiers

PMID41113188
PMCPMC12532009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.